CoChat

Systemic Elimination of de novo Capsid Protein Synthesis from Replication-Competent AAV Contamination in the Liver

Open access
Lu, Hui, Qu, Guang, Yang, Xiao, Xu, Ruian, Xiao, Weidong · 2011 · Human Gene Therapy
Cited by 14

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The capsid protein synthesis in targeted tissues resulting from residual contaminating replication-competent adeno-associated virus particles (rcAAV) remains a concern for hazardous immune responses that shut down the factor IX expression in the hemophilia B clinical trial. To systematically reduce/eliminate the effects of potential contaminating rcAAV particles, we designed a novel adeno-associated virus (AAV) helper (pH22mir) with a microRNA binding cassette containing multiple copies of liver-specific (hsa-mir-122) and hematopoietic-specific (has-mir-142-3p) sequences to specifically control cap gene expression. In 293 cells, the rep and cap gene from pH22mir functioned similarly to that of conventional helper pH22. The vector yields and compositions from pH22mir and pH22 were indistinguishable. The performance of vector produced in this new system was comparable to that of similar vectors produced by conventional methods. In the human hepatic cell line, the capsid expression was reduced significantly from cap-mir cassette driven by a cytomegalovirus promoter. In the liver, 99.9% of capsid expression could be suppressed and no cap expression could be detected by western blot. In summary, we demonstrated a new concept in reducing de novo capsid synthesis in the targeted tissue. This strategy may not only help AAV vectors in controlling undesirable capsid gene expression, but can also be adopted for lentiviral or adenoviral vector production. Replication-competent adeno-associated viral particles (rcAAV) are an undesirable contaminant of vector preparations that may affect transgene expression or elicit a hazardous immune response. In this study, Yuan and colleagues have designed a recombinant AAV (rAAV) vector production system to tightly control AAV rep and capsid activity from rcAAV particles. According to the authors, this new method does not have any effects on rAAV yield or affect rAAV vector performance and is compatible with all current rAAV production systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.2011.005

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 14

Metadata

Authors
Lu, H., Qu, G., Yang, X., Xu, R., & Xiao, W.
Venue
Human Gene Therapy
Published
2011-05
Volume
22
Issue
5
Pages
625-632
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2067859851
Cited by
14
References
9
FWCI
0.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic Elimination of de novo Capsid Protein Synthesis from Replication-Competent AAV Contamination in the Liver. https://app.cochat.ai/papers/10.1089/hum.2011.005
The paper
Lu, H., Qu, G., Yang, X., Xu, R., & Xiao, W. (2011). Systemic Elimination of de novo Capsid Protein Synthesis from Replication-Competent AAV Contamination in the Liver. Human Gene Therapy. https://doi.org/10.1089/hum.2011.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.